Stage IV melanoma carried a 24 month life expectancy three short years ago. That is what T.J. Sharpe’s first oncologist told him he was facing, after a visit to the ER for a fever turned into a metastatic melanoma diagnosis. His quest to overcome these long odds and beat cancer has taken him through two clinical trials, four immunotherapies, and six surgeries – all while sharing the highs and lows of cancer treatment on www.Philly.com. Fortunately, those three years have seen a great advance in melanoma treatments, one Mr. Sharpe has witnessed first-hand and shared with the world through his blog, advocacy speaking, and participation in conferences for cancer, biotechnology, and clinical trials. Being a husband and father (second child Tommy was born a mere four weeks before the diagnosis), his story combines the medicinal side of the current immunotherapy treatments being presented at the Labroots Cancer Research and Oncology event, alongside how these treatments affect everyday life. It also gives medical professionals, researchers, caretakers, and other cancer patients insight into getting the best, right care and how to overcome the avalanche of information and decisions that a cancer diagnosis brings. While he is sharing his patient perspective, T.J. will receive his 42nd dose of pembrolizumab, as part of the second clinical trial.